Recommending Privately Developed FemTech in Healthcare Part 2: Understanding Healthcare Professionals’ Responsibilities

By Anna Nelson, Maria Tzanou and Tsachi Keren-Paz In the previous blog, we introduced the issues associated with healthcare professionals (HCPs) recommending privately-developed FemTech apps. In this second blog, we turn our attention to regulatory considerations associated with this practice. There are two distinct questions which could be asked here: (1) whether HCPs should recommend […]

Read More…

Recommending Privately-Developed FemTech in Healthcare Part 1: Promises and Pitfalls

By Anna Nelson, Maria Tzanou and Tsachi Keren-Paz   Introduction  FemTech refers to apps and wearable devices (eg. smart breast pumps and bluetooth-enabled fertility monitors) purporting to empower women and non-binary users to manage their sexual, gynaecological and reproductive health. During their recent review of the data practices of period and fertility tracking apps, the […]

Read More…

Creating a consolidated EMAH (Early Medical Abortion at Home) medication pack: What has the impact been?

By Nathan Burley   Background  Up to seven medicines are provided for an early medical abortion, similar to the amount supplied after a heart attack. Abortifacients, analgesia, an anti-emetic, contraception and an antibiotic could be supplied, with each attendance resulting in at least four packs being given. Clinics providing this service may store a variety […]

Read More…

Breaking Barriers: Japan’s market test of emergency contraceptive pills and their intermediate results

By Hayase Hakariya   The Japanese government finally initiated a market test to sell emergency contraceptive pills (ECPs), levonorgestrel (approved in 2011 in Japan), or its generic product, at the designated pharmacies on 28th November 2023. This has been achieved through the long-lasting 6-year endeavours by individuals or voluntary groups to voice easier access for […]

Read More…

Should we abolish ‘Sexual and Reproductive Health’?

By Ezio De Nucci   Should we abolish ‘Sexual and Reproductive Health (SRH)? This provocative question might sound odd, especially after the US Supreme Court scrapped the federal right to abortion. Surely, we need more focus on ‘sexual and reproductive health’, not less! But actually, the issue is not as simple, especially after distinguishing between […]

Read More…

Contraception prescribing during the COVID-19 pandemic – opportunities and challenges

  By Malcolm Moffat, Tanha Begum, Emer Cullen & Judith Rankin When the COVID-19 pandemic began almost four years ago, few of us could have predicted the profound and enduring impact that the events of 2020 and 2021 would have on all our lives. Not least among those impacts were the effects that lockdown restrictions […]

Read More…

Application of a novel abortion care quality measurement tool (ACQTool) in Bangladesh

By Laura E Jacobson, Sarah E. Baum, Erin Pearson, Rezwana Chowdhury, Nirali M. Chakraborty, Julia M. Goodman, Caitlin Gerdts, & Blair G. Darney Measuring and improving quality of care is an essential part of ensuring safe and effective health services; however, until recently measuring the quality of abortion care has been hampered by a lack of shared definitions […]

Read More…